These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 19664838)

  • 21. Non-invasive estimation of liver fibrosis in non-alcoholic fatty liver disease using the 13 C-caffeine breath test.
    Park GJ; Wiseman E; George J; Katelaris PH; Seow F; Fung C; Ngu MC
    J Gastroenterol Hepatol; 2011 Sep; 26(9):1411-6. PubMed ID: 21557768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low serum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD.
    Savvidou S; Hytiroglou P; Orfanou-Koumerkeridou H; Panderis A; Frantzoulis P; Goulis J
    J Clin Gastroenterol; 2009 Sep; 43(8):765-72. PubMed ID: 19525862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High prevalence of metabolic complications in patients with non-alcoholic fatty liver disease.
    Friis-Liby I; Aldenborg F; Jerlstad P; Rundström K; Björnsson E
    Scand J Gastroenterol; 2004 Sep; 39(9):864-9. PubMed ID: 15513385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The epidemiology of nonalcoholic fatty liver disease in adults.
    Clark JM
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S5-10. PubMed ID: 16540768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical and histological features of non-alcoholic fatty liver disease].
    Shi JP; Xun YH; Hu CB; Zhang L; Liu H; Lou GQ; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombotic risk factors and liver histologic lesions in non-alcoholic fatty liver disease.
    Papatheodoridis GV; Chrysanthos N; Cholongitas E; Pavlou E; Apergis G; Tiniakos DG; Andrioti E; Theodossiades G; Archimandritis AJ
    J Hepatol; 2009 Nov; 51(5):931-8. PubMed ID: 19726097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography.
    Wong VW; Chu WC; Wong GL; Chan RS; Chim AM; Ong A; Yeung DK; Yiu KK; Chu SH; Woo J; Chan FK; Chan HL
    Gut; 2012 Mar; 61(3):409-15. PubMed ID: 21846782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
    Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and associated risk factors of non-alcoholic fatty liver disease in hospitalized patients.
    Radu C; Grigorescu M; Crisan D; Lupsor M; Constantin D; Dina L
    J Gastrointestin Liver Dis; 2008 Sep; 17(3):255-60. PubMed ID: 18836616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non-alcoholic fatty liver disease.
    Targher G; Bertolini L; Padovani R; Poli F; Scala L; Tessari R; Zenari L; Falezza G
    Diabet Med; 2006 Apr; 23(4):403-9. PubMed ID: 16620269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.
    Brzozowska MM; Ostapowicz G; Weltman MD
    J Gastroenterol Hepatol; 2009 Feb; 24(2):243-7. PubMed ID: 19215335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
    Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.
    Marchesini G; Bugianesi E; Forlani G; Cerrelli F; Lenzi M; Manini R; Natale S; Vanni E; Villanova N; Melchionda N; Rizzetto M
    Hepatology; 2003 Apr; 37(4):917-23. PubMed ID: 12668987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of non-alcoholic fatty liver disease to colorectal adenomatous polyps.
    Hwang ST; Cho YK; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Won KH; Jin W
    J Gastroenterol Hepatol; 2010 Mar; 25(3):562-7. PubMed ID: 20074156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonalcoholic fatty liver disease in severely obese subjects.
    Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
    Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease.
    Targher G; Bertolini L; Scala L; Cigolini M; Zenari L; Falezza G; Arcaro G
    Nutr Metab Cardiovasc Dis; 2007 Sep; 17(7):517-24. PubMed ID: 16928437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease.
    Petta S; Cammà C; Cabibi D; Di Marco V; Craxì A
    Aliment Pharmacol Ther; 2011 Oct; 34(7):757-66. PubMed ID: 21790685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome.
    Abid A; Taha O; Nseir W; Farah R; Grosovski M; Assy N
    J Hepatol; 2009 Nov; 51(5):918-24. PubMed ID: 19765850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased prevalence of atopic features in patients with psoriatic arthritis, but not in psoriasis vulgaris.
    Hajdarbegovic E; Nijsten T; Westgeest A; Habraken F; Hollestein L; Thio B
    J Am Acad Dermatol; 2013 Feb; 68(2):270-7. PubMed ID: 22921106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical predictors of fibrosis in patients with chronic liver disease.
    Stepanova M; Aquino R; Alsheddi A; Gupta R; Fang Y; Younossi Z
    Aliment Pharmacol Ther; 2010 May; 31(10):1085-94. PubMed ID: 20175770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.